NCT02473146 2024-02-02
ALFA1401
Versailles Hospital
Phase 2/3 Completed
Clinical Trials
4 trialsNCT02272478 2020-01-23
AML18
Cardiff University
Phase 2/3 Unknown
NCT00038805 2018-10-31
Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 2/3 Terminated
NCT00909168 2014-05-06
MYFLAI07
University Hospital, Udine, Italy
Phase 2/3 Completed